D

Dance Biopharm

13 employees

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Diabetes
Health Care
Medical

Date founded

2010

Funding rounds raised

Total raised

$25M

from 5 investors over 5 rounds

D

Dance Biopharm raised $13M on March 23, 2020

Investors: SternAegis Ventures

D

Dance Biopharm raised $21M on April 23, 2019

Investors: -

D

Dance Biopharm raised $25M on September 25, 2018

Investors: -

D

Dance Biopharm raised $14M on November 1, 2017

Investors: SternAegis Ventures

D

Dance Biopharm raised $20M on October 1, 2015

Investors: SternAegis Ventures

FAQ